Pharmaceutical Industry News
Sun Pharma Advanced Research Company Ltd. (SPARC) reported positive top-line results from its phase 3 trial (CLR_16_33) for its investigational drug, PDP-716 ophthalmic suspension, for the treatment of open angle glaucoma or ocular hypertension
Clinical Trials | 14/05/2021 | By Darshana
CNS Pharma completes manufacturing strategy for Berubicin to treat glioma brain tumors
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and CNS, provided an update on the manufacturing strategy for Berubicin drug product, its lead drug candidate for the treatment of glioma brain tumors
Clinical Trials | 17/07/2020 | By Darshana | 179
China to run human coronavirus vaccine trial in UAE
China National Biotec Group (CNBG) has won approval to run a large-scale Phase 3 clinical trial of its novel coronavirus vaccine candidate in the United Arab Emirates (UAE), the company said. China is seeking to trial potential vaccines overseas because of a lack of new patients at home
Clinical Trials | 25/06/2020 | By Darshana | 171
Roche today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC) and whose tumours had PTEN loss
Clinical Trials | 19/06/2020 | By Darshana | 163
The U.S. Food and Drug Administration has issued warning letters to three companies for marketing adulterated and misbranded COVID-19 antibody test
Clinical Trials | 18/06/2020 | By Darshana | 173
Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the investigational antiviral remdesivir, versus placebo plus remdesivir in hospitalised patients with severe COVID-19 pneumonia, in collaboration with Gilead Sciences, Inc
Clinical Trials | 28/05/2020 | By Darshana | 191
Today, the U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors ? non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers ? in patients whose tumors have an alteration (mutation or fusion) in a specific gene
Clinical Trials | 10/05/2020 | By Darshana | 132
ICMR announces protocol for Therapeutic Plasma Exchange therapy in COVID-19 patients
The Indian Council of Medical Research (ICMR) has announced protocol for a multi-center, phase II, open label, randomized controlled study named Therapeutic Plasma Exchange (TPE) in COVID-19 for its therapy. The therapy is also called convalescent plasma therapy which according to health experts has the potential to treat critically ill COVID-19 patient
Clinical Trials | 15/04/2020 | By Darshana | 133
Roche provides regulatory update on risdiplam for the treatment of spinal muscular atrophy (SMA)
Roche, announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the New Drug Application (NDA) of risdiplam with a decision expected by August 24, 2020
Clinical Trials | 13/04/2020 | By Darshana | 140
The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara in patients hospitalized with severe COVID-19. The global clinical program has now been initiated in Italy, Spain, Germany, France, Canada, Russia and the United States ? all countries that have been impacted by COVID-19
Clinical Trials | 30/03/2020 | By Darshana | 130
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy